Surgical outcomes in patients with cutaneous malignant melanoma in Europe - a systematic literature review

Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial

(2016) Andrew J Hayes et al.   LANCET ONCOLOGY

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

(2016) Ulrike Leiter et al.   LANCET ONCOLOGY

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) R. Dummer et al.   ANNALS OF ONCOLOGY

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report

(2015) M. Sladden et al.   BRITISH JOURNAL OF DERMATOLOGY

Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management

(2015) M.B. Faries et al.   BRITISH JOURNAL OF DERMATOLOGY

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

(2015) Alexander M M Eggermont et al.   LANCET ONCOLOGY

Surgical Management of Primary and Recurrent Melanoma

(2015) Jeffrey M. Farma et al.   Surgical Oncology Clinics of North America

Melanoma prognosis in Europe: far from equal

(2014) A.M. Forsea et al.   BRITISH JOURNAL OF DERMATOLOGY

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

(2014) Donald L. Morton et al.   NEW ENGLAND JOURNAL OF MEDICINE

The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases

(2013) M. Zdzienicki et al.   EJSO

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up

(2013) Josefine Beger et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

(2013) Roberta De Angelis et al.   LANCET ONCOLOGY

Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection

(2012) A. P. T. van der Ploeg et al.   BRITISH JOURNAL OF SURGERY

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012

(2012) Claus Garbe et al.   EUROPEAN JOURNAL OF CANCER

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

(2011) Peter Gillgren et al.   LANCET

Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM

(2011) F Egberts et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Sentinel Node Dissection Delays Recurrence and Prolongs Melanoma-Related Survival: An Analysis of 673 Patients from a Single Center with Long-Term Follow-Up

(2010) I. Satzger et al.   ANNALS OF SURGICAL ONCOLOGY

Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases

(2010) Sandro Pasquali et al.   CANCER

The Outcome of Patients with Melanoma Is Not Associated with the Time Point of Lymphatic Mapping with Respect to Excisional Biopsy of the Primary Tumor

(2010) Katharina J. Gauwerky et al.   DERMATOLOGY

Cutaneous melanoma with nodal metastases in elderly people

(2010) Piotr Rutkowski et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

Sentinel Lymph Node Dissection in Primary Melanoma Reduces Subsequent Regional Lymph Node Metastasis as Well as Distant Metastasis After Nodal Involvement

(2009) Ulrike Leiter et al.   ANNALS OF SURGICAL ONCOLOGY

Therapeutic Effect of Sentinel Lymph Node Biopsy in Melanoma Remains an Open Question

(2009) Phyllis A. Gimotty et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3)

(2008) Zbigniew I. Nowecki et al.   ANNALS OF SURGICAL ONCOLOGY

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

(2008) Inge S. van Houdt et al.   INTERNATIONAL JOURNAL OF CANCER